Abbott India appoints Devesh Choudhari as Director - Finance Ruchika Sharma1 April 2025 1:02 PM ISTMumbai: Abbott India has announced the appointment of Devesh Choudhari as Director - Finance effective April 1, 2025. He will be joining the...
Piramal Alternatives infuses Rs 110 crore in Biodeal Pharma Ruchika Sharma9 April 2024 3:38 PM ISTMumbai: Piramal Alternatives, the fund management division of the Piramal Group, has announced a significant investment of INR 110 Cr. in Biodeal...
Biocon engages law firm for governance review after CBI arrests Ruchika Sharma1 July 2022 2:30 PM ISTNew Delhi: Drugmaker Biocon Ltd. has engaged an external law firm to do a comprehensive review of its governance processes involving consultants and...
Carlyle Group to acquire 20pc stake in Piramal Pharma for Rs 3700 crore Farhat Nasim28 Jun 2020 10:30 AM IST"... CA Clover Intermediate II Investments, an affiliated entity of CAP V Mauritius Ltd, an investment fund managed and advised by affiliated entities...
Indian Pharma Industries likely to continue Chinese imports till feasible alternatives emerge Ruchika Sharma28 Jun 2020 9:15 AM ISTHe, however, added that the government has addressed the need to reduce import dependence by bringing in the bulk drug and medical devices policy.
Piramal Enterprises announces sale of BST-CarGel savita thakur thakur13 Jan 2016 3:09 AM ISTMUMBAI: Piramal Enterprises announced sale of BST-CarGel from Piramal Healthcare (Canada) Ltd to Smith & Nephew, a global medical technology...
Piramal Enterprises acquires five OTC brands for Rs 92 crore savita thakur thakur24 Dec 2015 11:31 AM ISTNew Delhi: Piramal Enterprises Ltd's (PEL) Consumer Products Division today announced acquisition of five brands from Organon India Pvt Ltd and MSD BV...
CCI approves Piramal-DiaSys deal savita thakur thakur19 Dec 2015 9:18 AM ISTNew Delhi: Fair trade regulator CCI today approved acquisition of Piramal Enterprises' lab diagnostics and point-of-care business by DiaSys India.In...
